Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 6, 2014, Pages 798-805

  Zhang, Qi ^a   Zhao, Zhongsheng ^a   Ma, Yingyu ^b   Wang, Huiju ^b   Ma, Jie ^a   He, Xujun ^b   Zhang, Dahong ^a  

^a ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b Key Laboratory of Gastroenterology of Zhejiang Province   (China)

Author keywords

Annexin A2; Prognosis; Prognostic marker; S100A4; Urothelial carcinoma

Indexed keywords

CALVASCULIN; LIPOCORTIN 2; PROTEIN S 100; S100A4 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA; TUMOR INVASION; UPREGULATION; BIOSYNTHESIS; BLADDER TUMOR; CANCER STAGING; CHI SQUARE DISTRIBUTION; DISEASE COURSE; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS;

ANNEXIN A2; CARCINOMA, TRANSITIONAL CELL; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; S100 PROTEINS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84905184591     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2014.02.009     Document Type: Article

References (26)

1. Sopkova-de O.S.J., Oling F.K., Rety S., Brisson A., Smith J.C., Lewit-Bentley A. S100 protein-annexin interactions: a model of the (Anx2-p11)(2) heterotetramer complex. Biochim Biophys Acta 2000, 1498:181-191.
2. Yang G.L., Zhang L.H., Bo J.J., et al. Increased expression of HMGB1 is associated with poor prognosis in human bladder cancer. J Surg Oncol 2012, 106:57-61.
3. Hussain S.A., James N.D. The systemic treatment of advanced and metastatic bladder cancer. Lancet Oncol 2003, 4:489-497.
4. Xue Y.J., Lu Q., Sun Z.X. CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer. Med Oncol 2011, 28:1363-1372.
5. Yafi F.A., North S., Kassouf W. First- and second-line therapy for metastatic urothelial carcinoma of the bladder. Curr Oncol 2011, 18:e25-e34.
6. der Maase H.v., Sengelov L., Roberts J.T., et al. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol 2005, 23:4602-4608.
7. Grigorian M.S., Tulchinsky E.M., Zain S., et al. The mts1 gene and control of tumor metastasis. Gene 1993, 135:229-238.
8. Matsumoto K., Irie A., Satoh T., et al. Expression of S100A2 and S100A4 predicts for disease progression and patient survival in bladder cancer. Urology 2007, 70:602-607.
9. Zhang Q., Ye Z., Yang Q., He X., Wang H., Zhao Z. Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer. World J Surg Oncol 2012, 10:103.
10. Lokman N.A., Ween M.P., Oehler M.K., Ricciardelli C. The role of annexin A2 in tumorigenesis and cancer progression. Cancer Microenviron 2011, 4:199-208.
11. Rintala-Dempsey A.C., Rezvanpour A., Shaw G.S. S100-annexin complexes-structural insights. FEBS J 2008, 275:4956-4966.
12. Lee W.Y., Su W.C., Lin P.W., Guo H.R., Chang T.W., Chen H.H. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer. Oncology 2004, 66:429-438.
13. Garrett S.C., Varney K.M., Weber D.J., A.R. Bresnick S100A4, a mediator of metastasis. J Biol Chem 2006, 281:677-680.
14. Helfman D.M., Kim E.J., Lukanidin E., Grigorian M. The metastasis associated protein S100A4: role in tumour progression and metastasis. Br J Cancer 2005, 92:1955-1958.
15. Hemandas A.K., Salto-Tellez M., Maricar S.H., Leong A.F., Leow C.K. Metastasis-associated protein S100A4-a potential prognostic marker for colorectal cancer. J Surg Oncol 2006, 93:498-503.
16. Kang Y.G., Jung C.K., Lee A., Kang W.K., Oh S.T., Kang C.S. Prognostic significance of S100A4 mRNA and protein expression in colorectal cancer. J Surg Oncol 2012, 105:119-124.
17. Boye K., Maelandsmo G.M. S100A4 and metastasis: a small actor playing many roles. Am J Pathol 2010, 176:528-535.
18. Semov A., Moreno M.J., Onichtchenko A., et al. Metastasis-associated protein S100A4 induces angiogenesis through interaction with Annexin II and accelerated plasmin formation. J Biol Chem 2005, 280:20833-20841.
19. van der Poel H.G. Foreseeing cancer metastases. Eur Urol 2006, 50:648-649.
20. Li Z.H., Bresnick A.R. The S100A4 metastasis factor regulates cellular motility via a direct interaction with myosin-IIA. Cancer Res 2006, 66:5173-5180.
21. Frances R., Tumang J.R., Rothstein T.L. Extreme skewing of annexin II and S100A6 expression identified by proteomic analysis of peritoneal B-1 cells. Int Immunol 2007, 19:59-65.
22. Diaz V.M., Hurtado M., Thomson T.M., Reventos J., Paciucci R. Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro. Gut 2004, 53:993-1000.
23. Emoto K., Yamada Y., Sawada H., et al. Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma. Cancer 2001, 92:1419-1426.
24. Sharma M.R., Koltowski L., Ownbey R.T., Tuszynski G.P., Sharma M.C. Angiogenesis-associated protein annexin II in breast cancer: selective expression in invasive breast cancer and contribution to tumor invasion and progression. Exp Mol Pathol 2006, 81:146-156.
25. Ohno Y., Izumi M., Kawamura T., Nishimura T., Mukai K., Tachibana M. Annexin II represents metastatic potential in clear-cell renal cell carcinoma. Br J Cancer 2009, 101:287-294.
26. Kwon M., MacLeod T.J., Zhang Y., Waisman D.M. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors. Front Biosci 2005, 10:300-325.